Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Veronica Olivo Pimentel"'
Autor:
Veronica Olivo Pimentel, Damiënne Marcus, Alexander MA van der Wiel, Natasja G Lieuwes, Rianne Biemans, Relinde IY Lieverse, Dario Neri, Jan Theys, Ala Yaromina, Ludwig J Dubois, Philippe Lambin
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 3 (2021)
Background Poorly immunogenic tumors are hardly responsive to immunotherapies such as immune checkpoint blockade (ICB) and are, therefore, a therapeutic challenge. Combination with other immunotherapies and/or immunogenic therapies, such as radiother
Externí odkaz:
https://doaj.org/article/79cc56a05cf2418c8eb72e923bf9ce7a
Autor:
Dina Al Dulaimi, Jihene Klibi, Veronica Olivo Pimentel, Veronique Parietti, Matthieu Allez, Antoine Toubert, Kamel Benlagha
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Natural killer group 2D (NKG2D) is a well-characterized activating receptor expressed on many immune cells, including invariant natural killer T (iNKT) cells. These cells were shown to be responsible of liver injury in the model of concanavalin A (Co
Externí odkaz:
https://doaj.org/article/f8049fd453884107a5023bd80937c703
Autor:
Nicolle H. Rekers, Veronica Olivo Pimentel, Ala Yaromina, Natasja G. Lieuwes, Rianne Biemans, Catharina M. L. Zegers, Wilfred T. V. Germeraad, Evert J. Van Limbergen, Dario Neri, Ludwig J. Dubois, Philippe Lambin
Publikováno v:
OncoImmunology, Vol 7, Iss 4 (2018)
Recently, we have shown that the administration of the tumour-targeted antibody-based immunocytokine L19-IL2 after radiotherapy (RT) resulted in synergistic anti-tumour effect. Here we show that RT and L19-IL2 can activate a curative abscopal effect,
Externí odkaz:
https://doaj.org/article/371eb8000c2f4cfaa75cfee345c249c1
Autor:
Eloy Moreno Roig, Arjan J. Groot, Ala Yaromina, Tessa C. Hendrickx, Lydie M. O. Barbeau, Lorena Giuranno, Glenn Dams, Jonathan Ient, Veronica Olivo Pimentel, Marike W. van Gisbergen, Ludwig J. Dubois, Marc A. Vooijs
Publikováno v:
Cells, Vol 8, Iss 1, p 45 (2019)
The hypoxia-inducible transcription factors (HIF)-1/2α are the main oxygen sensors which regulate the adaptation to intratumoral hypoxia. The aim of this study was to assess the role of the HIF proteins in regulating the radiation response of a non-
Externí odkaz:
https://doaj.org/article/a57a3bc6fa54419b86f08b433c6861ca
Autor:
Nynke Y. Rots, Martien C. M. Poelen, Veronica Olivo Pimentel, Maarten E. Emmelot, Jelle de Wit, Daphne F.M. Reukers, Cecile A C M van Els, Adam Meijer, Josine van Beek, Lisa Beckers, Rutger M. Schepp, Alper Cevirgel, Patricia Kaaijk, Gerco den Hartog
BackgroundSevere acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has led to considerable morbidity/mortality worldwide, but most infections, especially among children, have a mild course. However, it remains largely unknown whether infected chi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e97b8075c3e6d37a06d8dd993af376f4
https://doi.org/10.1101/2021.09.10.21263333
https://doi.org/10.1101/2021.09.10.21263333
Autor:
Ludwig Dubois, Jan Theys, Dario Neri, Natasja G. Lieuwes, Alexander M A van der Wiel, Ala Yaromina, R. Biemans, Veronica Olivo Pimentel, Relinde I Y Lieverse, Philippe Lambin, Damiënne Marcus
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 3 (2021)
Journal for ImmunoTherapy of Cancer, 9 (3)
Journal for ImmunoTherapy of Cancer, 9(3):001764. BioMed Central Ltd
Journal for ImmunoTherapy of Cancer
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, 9 (3)
Journal for ImmunoTherapy of Cancer, 9(3):001764. BioMed Central Ltd
Journal for ImmunoTherapy of Cancer
Journal for Immunotherapy of Cancer
BackgroundPoorly immunogenic tumors are hardly responsive to immunotherapies such as immune checkpoint blockade (ICB) and are, therefore, a therapeutic challenge. Combination with other immunotherapies and/or immunogenic therapies, such as radiothera
Publikováno v:
Journal of Immunological Methods
Journal of Immunological Methods, 487:112899. Elsevier Science
Journal of Immunological Methods, 487:112899. Elsevier Science
T cell immunotherapies have shown great promise in patients with advanced cancer disease, revolutionizing treatment. T cell cytotoxicity is crucial in its efficacy, therefore developing ex vivo methods testing tumor and T cell interactions is pivotal
Autor:
Glenn Dams, Marc Vooijs, Ala Yaromina, Marike W. van Gisbergen, Arjan J. Groot, Lydie M. O. Barbeau, Jonathan Ient, Eloy Moreno Roig, Veronica Olivo Pimentel, Ludwig Dubois, Lorena Giuranno, Tessa C. Hendrickx
Publikováno v:
Cells, Vol 8, Iss 1, p 45 (2019)
Cells
Volume 8
Issue 1
Cells, 8(1):45. Multidisciplinary Digital Publishing Institute (MDPI)
Cells
Volume 8
Issue 1
Cells, 8(1):45. Multidisciplinary Digital Publishing Institute (MDPI)
The hypoxia-inducible transcription factors (HIF)-1/2&alpha
are the main oxygen sensors which regulate the adaptation to intratumoral hypoxia. The aim of this study was to assess the role of the HIF proteins in regulating the radiation response
are the main oxygen sensors which regulate the adaptation to intratumoral hypoxia. The aim of this study was to assess the role of the HIF proteins in regulating the radiation response
Autor:
Ludwig Dubois, Catharina M.L. Zegers, Evert J. Van Limbergen, Nicolle H. Rekers, Ala Yaromina, Veronica Olivo Pimentel, Dario Neri, R. Biemans, Wilfred T. V. Germeraad, Natasja G. Lieuwes, Philippe Lambin
Publikováno v:
OncoImmunology, 7 (14)
Oncoimmunology
OncoImmunology
OncoImmunology, Vol 7, Iss 4 (2018)
OncoImmunology, 7(4):e1414119. Landes Bioscience
Oncoimmunology
OncoImmunology
OncoImmunology, Vol 7, Iss 4 (2018)
OncoImmunology, 7(4):e1414119. Landes Bioscience
Recently, we have shown that the administration of the tumour-targeted antibody-based immunocytokine L19-IL2 after radiotherapy (RT) resulted in synergistic anti-tumour effect. Here we show that RT and L19-IL2 can activate a curative abscopal effect,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a1af75ba4057815196cbc5908225ac9
https://hdl.handle.net/20.500.11850/238558
https://hdl.handle.net/20.500.11850/238558
Publikováno v:
Translational Cancer Research, 5(Suppl 6), S1292-S1294. AME Publishing Company
In his commentary, Claus Garbe described our study on the combination of radiotherapy (RT) and the immunocytokine L19-IL2 in the F9 fibrosarcoma model (1) and discussed our work in a checkpoint inhibitor related context. The author is positioning int